Stay updated with breaking news from 0fgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Rating) have been given an average rating of “Hold” by the seven brokerages that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have assigned a buy recommendation to the company. The […]
FibroGen (NASDAQ:FGEN – Get Rating) and Cocrystal Pharma (NASDAQ:COCP – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. Valuation and Earnings This table compares FibroGen and Cocrystal Pharma’s […]
Pinnacle Associates Ltd. lowered its position in FibroGen, Inc. (NASDAQ:FGEN – Get Rating) by 2.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 154,729 shares of the biopharmaceutical company’s stock after selling 3,995 shares during the quarter. Pinnacle Associates Ltd. owned 0.16% of […]
FibroGen, Inc. (NASDAQ:FGEN – Get Rating) SVP Christine Chung sold 6,590 shares of FibroGen stock in a transaction on Tuesday, April 4th. The stock was sold at an average price of $18.78, for a total transaction of $123,760.20. Following the completion of the transaction, the senior vice president now owns 252,460 shares in the company, […]
FibroGen, Inc. (NASDAQ:FGEN – Get Rating) SVP Christine Chung sold 6,590 shares of the business’s stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $18.78, for a total transaction of $123,760.20. Following the transaction, the senior vice president now owns 252,460 shares in the company, valued at […]